About: http://webisa.webdatacommons.org/163838809

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Given that most clinical trials for SMA are likely to involve young children, there is a need for validated molecular biomarkers to assist with monitoring disease progression and establishing the effectiveness of therapies being tested.
http://www.w3.org/ns/prov#wasQuotedFrom	pubmedcentralcanada.ca